“Our ability to perform both healthy volunteer trials as well as specialty trials with fullservices will garner efficiencies and drive quality for our partners” said Amy Young, vice president and general manager at DCR. “As research trends continue to involve patient studies earlier in the trial process, the ability to have real-time access to accurate data from a single organization becomes increasingly important.”
Employing software and fully validated systems, the data management services group demonstrates DCR’s ongoing commitment to offer best-in-class development capabilities. DCR has conducted more than 90 early clinical trials in more than 1,000 patients and healthy normal volunteers since 2009, including specialty populations and first-in-human studies. DCR now operates 122beds across two Phase I units in Minneapolis, Minn. and Denver, Colo.
The data management services team will be led by Michael Kreuter, director of DCR, who is located in Denver.
“Data integrity and patient safety are critical in Phase I clinical trial work,” saidKreuter. “We are building on DCR’s solid track record in those areas with a full range of data services necessary for early clinical work.”
Features of the data services group include:
Programmed systems using guidance from CDISC, ICH and other current guides
Client standards, which can be customized and used for future studies
Delivery of final datasets in industry standards including:
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.